Loading...
skip to Main Content

Last Friday, I had the opportunity to present the latest results of my PhD at the #NAFLDSummit 2022. Thank you @EASLnews for this enriching conference with the latest updates about NAFLD management, research, and the biggest challenges in the design of clinical trials. See you!

Honoured to have participated in #EASL #NAFLDsummit 2022 along with renowned experts:Dr.Tacke ,@phil_newsome7,@QAnstee,@scottfriedmanmd,and DrOliveira.Eyeopening experience,wish to meet you all soon,sure that the next one will be MAFLDsummit @EASLnews #MedTwitter #livertwitter

This episode is sponsored by @Resoundant

https://hubs.la/Q01mZb6f0

S3-E46 – A Review of the 2022 NAFLD Summit from Dublin

#NAFLDSummit #NASHMeeting #NAFLDMeeting #NASHpodcast #SurfingNASH #FattyLiver #NAFLDSummitDublin

EASL NAFLD Summit 2022

NAFLD is the leading cause of chronic liver disease, along with higher risk of diabetes, cardiovascular disease, and cancer, and thus a major public health challenge. NAFLD represents a therapeutic area of as yet unmet clinical lead.

This 4th iteration of the EASL NAFLD Summit brought together all stakeholders engaged in tackling NAFLD, including clinicians, researchers, policy and public health specialists, and industry professionals.

Together they:

  • explored in depth the most relevant developments and challenges
  • enjoyed a wide breadth of topics from disease mechanisms to biomarkers and models of care
  • explored the latest therapeutic developments
  • presented research and learned from peers
  • participated in panel-based discussions on controversial topics
  • learned about current and future clinical management in case-based multidisciplinary approaches
  • networked with key opinion leaders, and more.

On-demand access

Until 17 March 2023:
Exclusive access to on-demand content for registered delegates.

Best of Slide Deck

Meet the Faculty

Discover the Scientific Programme

The Summit featured ten scientific programme sessions reflecting on the current status of clinical trials, the knowledge and trends in the treatment of NAFLD and the future of research and treatment of NAFLD.

Supported by Fáilte Ireland

The EASL NAFLD Summit 2022 received an unrestricted grant from Fáilte Ireland and its official business tourism brand “Meet in Ireland”.

Last Friday, I had the opportunity to present the latest results of my PhD at the #NAFLDSummit 2022. Thank you @EASLnews for this enriching conference with the latest updates about NAFLD management, research, and the biggest challenges in the design of clinical trials. See you!

Honoured to have participated in #EASL #NAFLDsummit 2022 along with renowned experts:Dr.Tacke ,@phil_newsome7,@QAnstee,@scottfriedmanmd,and DrOliveira.Eyeopening experience,wish to meet you all soon,sure that the next one will be MAFLDsummit @EASLnews #MedTwitter #livertwitter

This episode is sponsored by @Resoundant

https://hubs.la/Q01mZb6f0

S3-E46 – A Review of the 2022 NAFLD Summit from Dublin

#NAFLDSummit #NASHMeeting #NAFLDMeeting #NASHpodcast #SurfingNASH #FattyLiver #NAFLDSummitDublin

Back To Top